Chan Yue Li
Director/Board Member bij TAIWAN LIPOSOME COMPANY, LTD.
Profiel
Chan Yue Li currently works at Taiwan Liposome Co., Ltd., as Director from 2014, Steminent Biotherapeutics, Inc., as Director from 2021, and Lin BioScience, Inc., as Director from 2016.
Mr. Li also formerly worked at UBI Pharma Inc., as Director.
Mr. Li received his graduate degree from the University of Iowa.
Actieve functies van Chan Yue Li
Bedrijven | Functie | Begin |
---|---|---|
TAIWAN LIPOSOME COMPANY, LTD. | Director/Board Member | 18-06-2014 |
LIN BIOSCIENCE, INC. | Director/Board Member | 13-10-2016 |
STEMINENT BIOTHERAPEUTICS, INC | Director/Board Member | 08-12-2021 |
Eerdere bekende functies van Chan Yue Li
Bedrijven | Functie | Einde |
---|---|---|
UBI PHARMA INC. | Director/Board Member | - |
Opleiding van Chan Yue Li
University of Iowa | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
STEMINENT BIOTHERAPEUTICS, INC | Health Technology |
UBI PHARMA INC. | Health Technology |
LIN BIOSCIENCE, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Taiwan Liposome Co., Ltd.
Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |